Search

everythinglearnresearchcommunity

for

Search:↓

Graphene oxide helps deliver a skin healing agent over time, improving skin and hair follicle regeneration.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Keratin hydrogel from human hair is a promising biocompatible material for soft tissue fillers.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Tissue stiffness is influenced by contractility, which suppresses collagen breakdown.

The hair follicle's connective tissue is a key source of a certain collagen in human scalp skin.

Knockout mice showed anemia and hair loss, suggesting other ways exist for iron absorption.

A treatment called Cellcurin, combined with microneedling, significantly increased hair density and diameter in patients with hair loss.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Finasteride reduces alcohol consumption in mice by affecting brain chemicals.

A rare case of a man having both frontal fibrosing alopecia and vitiligo was reported.

Type III collagen increases in recovering guinea pig skin, aiding tissue stability.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Intermediate filaments are crucial for cell structure and function, regulated by specific genes and proteins.

No link found between blood groups, Rhesus factor, and ferritin levels in women with hair loss.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Myo-inositol and D-chiro-inositol, especially in a 40:1 ratio, effectively treat PCOS by improving insulin sensitivity and ovulation.

Injections improve hair growth, density, and thickness in women safely.

Liposomal IGF-1 safely and effectively treats hair loss in hamsters.